Description
PI-1840 is a is a novel rapidly reversible proteasome inhibitor with antitumor activity. It shows selective inhibitor for chymotrypsin-like (CT-L) over trypsin-like and peptidylglutamyl peptide hydrolyzing activities of the proteasome.
Product information
CAS Number: 1401223-22-0
Molecular Weight: 394.47
Formula: C22H26N4O3
Chemical Name: N-(propan-2-yl)-2-(4-propylphenoxy)-N-{[3-(pyridin-3-yl)-1,2,4-oxadiazol-5-yl]methyl}acetamide
Smiles: CCCC1C=CC(=CC=1)OCC(=O)N(CC1=NC(=NO1)C1=CN=CC=C1)C(C)C
InChiKey: ZVVXAODXPVWGMF-UHFFFAOYSA-N
InChi: InChI=1S/C22H26N4O3/c1-4-6-17-8-10-19(11-9-17)28-15-21(27)26(16(2)3)14-20-24-22(25-29-20)18-7-5-12-23-13-18/h5,7-13,16H,4,6,14-15H2,1-3H3
Technical Data
Appearance: Solid Power
Purity: ≥98% (or refer to the Certificate of Analysis)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical or refer to Certificate of Analysis
Storage Condition: Dry, dark and -20 oC for 1 year or refer to the Certificate of Analysis.
Shelf Life: ≥360 days if stored properly.
Stock Solution Storage: 0 - 4 oC for 1 month or refer to the Certificate of Analysis.
Drug Formulation: To be determined
HS Tariff Code: 382200
Products are for research use only. Not for human use.
Payment & Security
Your payment information is processed securely. We do not store credit card details nor have access to your credit card information.